Peer Review History
| Original SubmissionMay 30, 2025 |
|---|
|
Dear Dr. Min, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== ACADEMIC EDITOR: ============================== Please submit your revised manuscript by Aug 28 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Ahmet Çağlar, Associate Professor Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. In the online submission form, you indicated that [The data for the present study is available from the corresponding author on reasonable request.]. All PLOS journals now require all data underlying the findings described in their manuscript to be freely available to other researchers, either 1. In a public repository, 2. Within the manuscript itself, or 3. Uploaded as supplementary information. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If your data cannot be made publicly available for ethical or legal reasons (e.g., public availability would compromise patient privacy), please explain your reasons on resubmission and your exemption request will be escalated for approval. 3. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript. 4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 5. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Additional Editor Comments: I read the manuscript. I think it is well designed and written. I will reconsider it once major revisions have been made. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Partly Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: I Don't Know ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: Thank you for giving me the opportunity to review this study. This study was a randomized crossover design conducted on a manikin to compare the force applied to tissues by laryngoscopy, intubation characteristics, and ergonomics at two different bed heights. The hypothesis was that less force would be required when the bed height was at the xiphoid process level compared to the ASIS level. The primary outcome was the peak laryngoscopy force during the intubation process. The results showed that the mean peak force and impulse force were greater at the ASIS height compared to the xiphoid height, but there was no difference in average force. At the xiphoid height, subjective discomfort levels and ergonomic stress were lower, and the laryngeal view was better. The study was well-designed, conducted, and analyzed, and the manuscript was logically written. I have a few minor comments: • It is necessary to interpret this study in relation to previous studies that compared intubation procedures at various bed heights, including "Signae Vitae Vol.12, Issue S1, October 2016 pp.47-51" and "J Am Coll Emerg Physicians Open. 2020 Mar 13;1(3):257-262." • The sentence on Line 312, " Therefore, decreasing impulse force would be helpful for patients with cardiovascular disease, intracranial pathology, or hypertension." needs to be toned down slightly. • While the limitations of using a manikin in a study, rather than actual clinical settings, were acknowledged, it is necessary to elaborate further on the need to confirm whether the same results would be observed in diverse real clinical environments, considering all aspects such as patients, operators, and environments. • The conclusion contains statements unrelated to the observations made in this study. The conclusion needs to be rewritten based on the results obtained from this research. Reviewer #2: I appreciate your permission to examine the manuscript. I appreciate your confidence in my expertise and have enjoyed participating in the peer review process of this journal. This study provides a practical solution to reduce laryngoscopy force and improve ergonomics. It will be more effective if the suggested revisions are addressed, particularly the clinical context for force reductions and simulation limitations. 1. In limitations of simulation (p. 16), please clarify key differences between manikin vs. human airways (e.g., tissue compliance, hemodynamic responses). Future clinical validation (e.g., measuring plasma catecholamines or airway injury rates) is recommended. 2. How to handle missing data (pp. 9–10), 7 operators were excluded in period 2 due to sensor damage. Though IPW was used, please include sensitivity analyses of datasets (e.g., complete-case vs. imputed) in the supplementary material. Discuss the potential impact of missing data on statistical power in the limitations. 3. In the clinical relevance of peak force reduction (p. 11) section, the peak force reduction (2.38 N2.38N, ~7%) was borderline significant (p=0.049p=0.049). Please discuss clinical thresholds for tissue injury (e.g., compare with forces in studies of difficult airways or video laryngoscopy, such as Hindman et al.). Contrast the 7% reduction with larger reductions from advanced devices (e.g., ~30–40% with video laryngoscopy). 4. In the ergonomic interpretation section (pp. 14–15), REBA scores indicated "high risk" at height A (8.32) vs. "medium risk" at X (6.09). You can add practical guidance: "Adjust bed height to xiphoid level, especially for prolonged procedures or taller operators." Please emphasize the long-term impact of reducing work-related musculoskeletal disorders. 5. In the Introduction (p. 5), cite prevalence data for laryngeal injury early (e.g., "0.5–7%," Refs. 5–6) to underscore clinical urgency. Explicitly link bed height → laryngeal view → force reduction in the proposed mechanism. 6. In the supplementary materials section (pp. 27–30), you can add operator posture images at heights A/X to visualize REBA differences (replace placeholder Fig 2a/b). Share raw force datasets per PLOS ONE policy (e.g., via repository or supplementary files). ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Effect of bed height on laryngoscopy force and operator ergonomics during simulated endotracheal intubation: a randomized controlled study PONE-D-25-28136R1 Dear Dr. Min, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Ahmet Çağlar, Associate Professor Academic Editor PLOS ONE Additional Editor Comments (optional): Dear Authors, Thanks for the revisions. After major revisions, it is now suitable to be published in Plos One. Well done. Your sincerely. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: Thank you for the revised manuscript. The authors have effectively addressed all of my comments and concerns. I feel the paper is now in good shape and recommend accepting it for publication. Reviewer #2: Dear, As the reviewer of this manuscript, I am pleased to confirm that the authors have thoroughly and thoughtfully addressed all the points and concerns I raised in my initial assessment. The manuscript is now markedly improved, with a more robust methodology, a more nuanced interpretation of the results, and a more straightforward presentation of its contribution to the field. It now meets the high standards required for publication. Best regards ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: Yes: Afshin Khazaei ********** |
| Formally Accepted |
|
PONE-D-25-28136R1 PLOS ONE Dear Dr. Min, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Ahmet Çağlar Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .